High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning (Q35847466)

From Wikidata

Jump to navigation Jump to search

scientific article published on 8 June 2015

Language	Label	Description	Also known as
English	High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning	scientific article published on 8 June 2015

Statements

scholarly article

1 reference

Europe PubMed Central

10 August 2017

High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning (English)

1 reference

Europe PubMed Central

10 August 2017

17

object named as

Rosemarie Mick

1 reference

Europe PubMed Central

10 August 2017

David L. Porter

18

object named as

David L Porter

1 reference

Europe PubMed Central

10 August 2017

Edward A. Stadtmauer

15

object named as

Edward A Stadtmauer

1 reference

Europe PubMed Central

10 August 2017

5

object named as

Noelle V Frey

1 reference

Europe PubMed Central

10 August 2017

Elizabeth O. Hexner

7

object named as

Elizabeth O Hexner

1 reference

Europe PubMed Central

10 August 2017

Alison Wakoff Loren

9

object named as

Alison W Loren

1 reference

Europe PubMed Central

10 August 2017

10

object named as

Selina M Luger

1 reference

Europe PubMed Central

10 August 2017

1

object named as

Ran Reshef

1 reference

Europe PubMed Central

10 August 2017

Robert H Vonderheide

16

object named as

Robert H Vonderheide

1 reference

Europe PubMed Central

10 August 2017

11

object named as

James K Mangan

1 reference

Europe PubMed Central

10 August 2017

6

object named as

Saar I Gill

1 reference

Europe PubMed Central

10 August 2017

12

object named as

Sunita D Nasta

1 reference

Europe PubMed Central

10 August 2017

Marlise R Luskin

4

object named as

Marlise R Luskin

1 reference

Europe PubMed Central

10 August 2017

13

object named as

Lee P Richman

1 reference

Europe PubMed Central

10 August 2017

author name string

Austin P Huffman

2

1 reference

Europe PubMed Central

10 August 2017

Amy Gao

3

1 reference

Europe PubMed Central

10 August 2017

Taku Kambayashi

8

1 reference

Europe PubMed Central

10 August 2017

Mary Sell

14

1 reference

Europe PubMed Central

10 August 2017

language of work or name

0 references

publication date

8 June 2015

1 reference

Europe PubMed Central

10 August 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

10 August 2017

33

1 reference

Europe PubMed Central

10 August 2017

2392-2398

1 reference

Europe PubMed Central

10 August 2017

21

1 reference

Europe PubMed Central

10 August 2017

Impact of donor age on outcome after allogeneic hematopoietic cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500833

11 July 2018

Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500833

11 July 2018

Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500833

11 July 2018

Interindividual variation in human T regulatory cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500833

11 July 2018

Pre-transplant prognostic factors of long-term survival after allogeneic peripheral blood stem cell transplantation with matched related/unrelated donors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500833

11 July 2018

Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500833

11 July 2018

Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500833

11 July 2018

Blood CD33(+)HLA-DR(-) myeloid-derived suppressor cells are increased with age and a history of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500833

11 July 2018

Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500833

11 July 2018

Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500833

11 July 2018

Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500833

11 July 2018

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantatio

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500833

11 July 2018

Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500833

11 July 2018

Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500833

11 July 2018

Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500833

11 July 2018

Improved strategy for mononuclear cell collection for donor lymphocyte infusions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500833

11 July 2018

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500833

11 July 2018

1994 Consensus Conference on Acute GVHD Grading

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500833

11 July 2018

HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500833

24 September 2018

Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500833

24 September 2018

Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500833

24 September 2018

Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500833

24 September 2018

Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell dose

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500833

24 September 2018

Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500833

24 September 2018

Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500833

24 September 2018

CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling tr

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4500833

24 September 2018

Effect of CD8⁺ cell content on umbilical cord blood transplantation in adults with hematological malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/26056179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphocyte collection for donor leucocyte infusion from normal donors: estimation of the minimum processed blood volume and safety of the procedure

1 reference

https://pubmed.ncbi.nlm.nih.gov/26056179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age

1 reference

https://pubmed.ncbi.nlm.nih.gov/26056179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26056179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/26056179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD34, CD4, and CD8 cell doses do not influence engraftment, graft-versus-host disease, or survival following myeloablative human leukocyte antigen-identical peripheral blood allografting for hematologic malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/26056179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?

1 reference

https://pubmed.ncbi.nlm.nih.gov/26056179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/26056179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26056179

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2014.60.1203

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35847466&oldid=2089577810"